Gables Capital Management Inc. Purchases Shares of 2,800 Astera Labs, Inc. $ALAB

Gables Capital Management Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel reports. The fund acquired 2,800 shares of the company’s stock, valued at approximately $1,352,000.

Other institutional investors also recently modified their holdings of the company. Glenmede Trust Co. NA lifted its stake in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the last quarter. Lido Advisors LLC increased its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after buying an additional 57 shares during the last quarter. Goldstein Advisors LLC raised its stake in Astera Labs by 5.8% in the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after buying an additional 88 shares during the period. Bell Investment Advisors Inc acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $43,000. Finally, Great Valley Advisor Group Inc. lifted its position in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after buying an additional 90 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALAB has been the topic of a number of recent analyst reports. Royal Bank Of Canada boosted their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a report on Monday. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Finally, Roth Capital reissued a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average target price of $333.00.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $1,092,964.15. Following the sale, the director directly owned 53,961 shares in the company, valued at $16,826,658.63. This represents a 6.10% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 631,979 shares of company stock valued at $215,479,247 in the last three months. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Trading Down 5.2%

Shares of NASDAQ ALAB opened at $303.44 on Wednesday. The firm has a market cap of $52.64 billion, a P/E ratio of 150.22 and a beta of 3.84. The business’s 50 day moving average is $356.72 and its 200-day moving average is $242.75. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.